The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Enramycin Premix-Global Market Insights and Sales Trends 2025
Synopsis
Enramycin premix is formulated with enramycin, rice bran oil and corn flour. This product is a gray or gray-brown powder with a special odor. It is fermented by actinomycetes and is an unsaturated fatty acid. Polypeptide antibiotics combined with more than a dozen amino acids. It has a strong inhibitory effect on Gram-positive bacteria, and it is not easy to develop drug resistance after long-term use. It can change the distribution of bacterial communities in the intestinal tract, is conducive to the digestion and absorption of feed nutrients, promotes animal growth and improves feed conversion rate, so it is recommended as a pharmaceutical feed additive by many countries in the world. Enramycin is not easily absorbed, so there are fewer drug residues in the body of livestock and poultry.
The global Enramycin Premix market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Enramycin Premix in various end use industries. The expanding demands from the Pig Fodder, Chicken Fodder and Others,, are propelling Enramycin Premix market. Contains Enramycin 4%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Contains Enramycin 8% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Enramycin Premix market, driven by demand from China, the second largest economy with some signs of stabilising, the Enramycin Premix market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enramycin Premix, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enramycin Premix market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enramycin Premix market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enramycin Premix sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enramycin Premix covered in this report include Takeda, AdvaCare, Phiphar Healthcare, Boehringer Ingelheim, Eli Lilly and Company, Ravioza Biotech, Zhejiang Dayang Biology Technology, Bornsun Bioengineering and Shandong Shengli Bioengineering, etc.
The global Enramycin Premix market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
AdvaCare
Phiphar Healthcare
Boehringer Ingelheim
Eli Lilly and Company
Ravioza Biotech
Zhejiang Dayang Biology Technology
Bornsun Bioengineering
Shandong Shengli Bioengineering
Apeloa Pharmaceutical
Hvsen Biotechnology
Global Enramycin Premix market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enramycin Premix market, Segment by Type:
Contains Enramycin 4%
Contains Enramycin 8%
Global Enramycin Premix market, by Application
Pig Fodder
Chicken Fodder
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Enramycin Premix manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Enramycin Premix in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Enramycin premix is formulated with enramycin, rice bran oil and corn flour. This product is a gray or gray-brown powder with a special odor. It is fermented by actinomycetes and is an unsaturated fatty acid. Polypeptide antibiotics combined with more than a dozen amino acids. It has a strong inhibitory effect on Gram-positive bacteria, and it is not easy to develop drug resistance after long-term use. It can change the distribution of bacterial communities in the intestinal tract, is conducive to the digestion and absorption of feed nutrients, promotes animal growth and improves feed conversion rate, so it is recommended as a pharmaceutical feed additive by many countries in the world. Enramycin is not easily absorbed, so there are fewer drug residues in the body of livestock and poultry.
The global Enramycin Premix market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Enramycin Premix in various end use industries. The expanding demands from the Pig Fodder, Chicken Fodder and Others,, are propelling Enramycin Premix market. Contains Enramycin 4%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Contains Enramycin 8% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Enramycin Premix market, driven by demand from China, the second largest economy with some signs of stabilising, the Enramycin Premix market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enramycin Premix, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enramycin Premix market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enramycin Premix market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enramycin Premix sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enramycin Premix covered in this report include Takeda, AdvaCare, Phiphar Healthcare, Boehringer Ingelheim, Eli Lilly and Company, Ravioza Biotech, Zhejiang Dayang Biology Technology, Bornsun Bioengineering and Shandong Shengli Bioengineering, etc.
The global Enramycin Premix market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
AdvaCare
Phiphar Healthcare
Boehringer Ingelheim
Eli Lilly and Company
Ravioza Biotech
Zhejiang Dayang Biology Technology
Bornsun Bioengineering
Shandong Shengli Bioengineering
Apeloa Pharmaceutical
Hvsen Biotechnology
Global Enramycin Premix market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enramycin Premix market, Segment by Type:
Contains Enramycin 4%
Contains Enramycin 8%
Global Enramycin Premix market, by Application
Pig Fodder
Chicken Fodder
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Enramycin Premix manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Enramycin Premix in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Enramycin Premix Market Overview
1.1 Enramycin Premix Product Overview
1.2 Enramycin Premix Market Segment by Type
1.2.1 Contains Enramycin 4%
1.2.2 Contains Enramycin 8%
1.3 Global Enramycin Premix Market Size by Type
1.3.1 Global Enramycin Premix Market Size Overview by Type (2018-2029)
1.3.2 Global Enramycin Premix Historic Market Size Review by Type (2018-2023)
1.3.3 Global Enramycin Premix Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.2 Europe Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Enramycin Premix Sales Breakdown by Type (2018-2023)
2 Global Enramycin Premix Market Competition by Company
2.1 Global Top Players by Enramycin Premix Sales (2018-2023)
2.2 Global Top Players by Enramycin Premix Revenue (2018-2023)
2.3 Global Top Players by Enramycin Premix Price (2018-2023)
2.4 Global Top Manufacturers Enramycin Premix Manufacturing Base Distribution, Sales Area, Product Type
2.5 Enramycin Premix Market Competitive Situation and Trends
2.5.1 Enramycin Premix Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Enramycin Premix Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enramycin Premix as of 2022)
2.7 Date of Key Manufacturers Enter into Enramycin Premix Market
2.8 Key Manufacturers Enramycin Premix Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Enramycin Premix Status and Outlook by Region
3.1 Global Enramycin Premix Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Enramycin Premix Historic Market Size by Region
3.2.1 Global Enramycin Premix Sales in Volume by Region (2018-2023)
3.2.2 Global Enramycin Premix Sales in Value by Region (2018-2023)
3.2.3 Global Enramycin Premix Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Enramycin Premix Forecasted Market Size by Region
3.3.1 Global Enramycin Premix Sales in Volume by Region (2024-2029)
3.3.2 Global Enramycin Premix Sales in Value by Region (2024-2029)
3.3.3 Global Enramycin Premix Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Enramycin Premix by Application
4.1 Enramycin Premix Market Segment by Application
4.1.1 Pig Fodder
4.1.2 Chicken Fodder
4.1.3 Others
4.2 Global Enramycin Premix Market Size by Application
4.2.1 Global Enramycin Premix Market Size Overview by Application (2018-2029)
4.2.2 Global Enramycin Premix Historic Market Size Review by Application (2018-2023)
4.2.3 Global Enramycin Premix Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.2 Europe Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Enramycin Premix Sales Breakdown by Application (2018-2023)
5 North America Enramycin Premix by Country
5.1 North America Enramycin Premix Historic Market Size by Country
5.1.1 North America Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Enramycin Premix Sales in Volume by Country (2018-2023)
5.1.3 North America Enramycin Premix Sales in Value by Country (2018-2023)
5.2 North America Enramycin Premix Forecasted Market Size by Country
5.2.1 North America Enramycin Premix Sales in Volume by Country (2024-2029)
5.2.2 North America Enramycin Premix Sales in Value by Country (2024-2029)
6 Europe Enramycin Premix by Country
6.1 Europe Enramycin Premix Historic Market Size by Country
6.1.1 Europe Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Enramycin Premix Sales in Volume by Country (2018-2023)
6.1.3 Europe Enramycin Premix Sales in Value by Country (2018-2023)
6.2 Europe Enramycin Premix Forecasted Market Size by Country
6.2.1 Europe Enramycin Premix Sales in Volume by Country (2024-2029)
6.2.2 Europe Enramycin Premix Sales in Value by Country (2024-2029)
7 Asia-Pacific Enramycin Premix by Region
7.1 Asia-Pacific Enramycin Premix Historic Market Size by Region
7.1.1 Asia-Pacific Enramycin Premix Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Enramycin Premix Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Enramycin Premix Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Enramycin Premix Forecasted Market Size by Region
7.2.1 Asia-Pacific Enramycin Premix Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Enramycin Premix Sales in Value by Region (2024-2029)
8 Latin America Enramycin Premix by Country
8.1 Latin America Enramycin Premix Historic Market Size by Country
8.1.1 Latin America Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Enramycin Premix Sales in Volume by Country (2018-2023)
8.1.3 Latin America Enramycin Premix Sales in Value by Country (2018-2023)
8.2 Latin America Enramycin Premix Forecasted Market Size by Country
8.2.1 Latin America Enramycin Premix Sales in Volume by Country (2024-2029)
8.2.2 Latin America Enramycin Premix Sales in Value by Country (2024-2029)
9 Middle East and Africa Enramycin Premix by Country
9.1 Middle East and Africa Enramycin Premix Historic Market Size by Country
9.1.1 Middle East and Africa Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Enramycin Premix Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Enramycin Premix Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Enramycin Premix Forecasted Market Size by Country
9.2.1 Middle East and Africa Enramycin Premix Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Enramycin Premix Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Enramycin Premix Products Offered
10.1.5 Takeda Recent Development
10.2 AdvaCare
10.2.1 AdvaCare Company Information
10.2.2 AdvaCare Introduction and Business Overview
10.2.3 AdvaCare Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AdvaCare Enramycin Premix Products Offered
10.2.5 AdvaCare Recent Development
10.3 Phiphar Healthcare
10.3.1 Phiphar Healthcare Company Information
10.3.2 Phiphar Healthcare Introduction and Business Overview
10.3.3 Phiphar Healthcare Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Phiphar Healthcare Enramycin Premix Products Offered
10.3.5 Phiphar Healthcare Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boehringer Ingelheim Enramycin Premix Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Information
10.5.2 Eli Lilly and Company Introduction and Business Overview
10.5.3 Eli Lilly and Company Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly and Company Enramycin Premix Products Offered
10.5.5 Eli Lilly and Company Recent Development
10.6 Ravioza Biotech
10.6.1 Ravioza Biotech Company Information
10.6.2 Ravioza Biotech Introduction and Business Overview
10.6.3 Ravioza Biotech Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ravioza Biotech Enramycin Premix Products Offered
10.6.5 Ravioza Biotech Recent Development
10.7 Zhejiang Dayang Biology Technology
10.7.1 Zhejiang Dayang Biology Technology Company Information
10.7.2 Zhejiang Dayang Biology Technology Introduction and Business Overview
10.7.3 Zhejiang Dayang Biology Technology Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zhejiang Dayang Biology Technology Enramycin Premix Products Offered
10.7.5 Zhejiang Dayang Biology Technology Recent Development
10.8 Bornsun Bioengineering
10.8.1 Bornsun Bioengineering Company Information
10.8.2 Bornsun Bioengineering Introduction and Business Overview
10.8.3 Bornsun Bioengineering Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bornsun Bioengineering Enramycin Premix Products Offered
10.8.5 Bornsun Bioengineering Recent Development
10.9 Shandong Shengli Bioengineering
10.9.1 Shandong Shengli Bioengineering Company Information
10.9.2 Shandong Shengli Bioengineering Introduction and Business Overview
10.9.3 Shandong Shengli Bioengineering Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shandong Shengli Bioengineering Enramycin Premix Products Offered
10.9.5 Shandong Shengli Bioengineering Recent Development
10.10 Apeloa Pharmaceutical
10.10.1 Apeloa Pharmaceutical Company Information
10.10.2 Apeloa Pharmaceutical Introduction and Business Overview
10.10.3 Apeloa Pharmaceutical Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Apeloa Pharmaceutical Enramycin Premix Products Offered
10.10.5 Apeloa Pharmaceutical Recent Development
10.11 Hvsen Biotechnology
10.11.1 Hvsen Biotechnology Company Information
10.11.2 Hvsen Biotechnology Introduction and Business Overview
10.11.3 Hvsen Biotechnology Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hvsen Biotechnology Enramycin Premix Products Offered
10.11.5 Hvsen Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Enramycin Premix Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Enramycin Premix Industrial Chain Analysis
11.4 Enramycin Premix Market Dynamics
11.4.1 Enramycin Premix Industry Trends
11.4.2 Enramycin Premix Market Drivers
11.4.3 Enramycin Premix Market Challenges
11.4.4 Enramycin Premix Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Enramycin Premix Distributors
12.3 Enramycin Premix Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
